Patients suffering from primary biliary cholangitis may soon have hope, thanks to encouraging results from a clinical trial administered at UC Davis Health and around the globe.
Read MoreJuan Velasco became one of the first patients to receive a liver transplant at UC Davis Health after being diagnosed with cirrhosis of the liver.
Read MoreFour physicians from gastroenterology and hepatology were recognized this month by the American College of Gastroenterology.
Read MoreA recent report illuminates disparities between cancer patients in persistent poverty and non-persistent poverty areas of California.
Read MoreUC Davis Health is marking 20 years of offering robot-assisted surgery, as it continues to be a leader in offering minimally invasive, quality surgical care.
Read MoreResearchers have infused their first Wilson Disease patient with a gene therapy which has the potential to treat the underlying cause of the disease.
Read MoreInterventional gastroenterologists are offering a broad repertoire of new endoscopic procedures for patients out of the medical center's new leading-edge endoscopy suite.
Read MoreGastroenterology team members recently took part in the fifth annual Rwandan Endoscopy Week — helping deliver specialist consultations, endoscopic procedures and training in Rwanda.
Read MoreA new outpatient endoscopy suite is now open on the second floor of UC Davis Medical Center. It serves patients from gastroenterology, interventional pulmonology and colorectal surgery.
Read MorePatients with gastroesophageal reflux disease (GERD) can now get comprehensive testing and surgical management in a single location at UC Davis Health. The Surgery Foregut & Esophageal Motility Center now offers pH Acid reflux testing, esophageal manometry/motility testing, and endoscopy.
Read MoreChristopher Bowlus is the lead author of new guidelines for the management of primary sclerosing cholangitis, a chronic liver disease and bile duct cancer, called cholangiocarcinoma. The guidelines highlight best practices for the diagnosis and treatment of patients.
Read MoreResearchers have performed a first-of-its-kind study to better understand why non-alcoholic fatty liver disease affects certain races or ethnicities disproportionately. Initial findings suggest ethnicity-specific lipidomic signatures may characterize and explain the progression of the disease for certain races.
Read More